Comparison of temporary and permanent stent placement with concurrent radiation therapy in patients with esophageal carcinoma.

PURPOSE To assess the clinical effectiveness of temporary metallic stent placement with concurrent radiation therapy in patients with esophageal carcinoma by comparing it with permanent stent placement with concurrent radiation therapy. MATERIALS AND METHODS Covered retrievable expandable nitinol stents were placed in 47 patients with esophageal carcinoma 1 week before starting radiation therapy; the stents were electively removed 4 weeks after placement in 24 patients (group A), while not electively removed in the other 23 patients (group B). In cases of complications, the stents were also removed from patients in groups A and B. The dysphagia score, complications (severe pain, granulation tissue formation, stent migration, esophagorespiratory fistula, and hematemesis), tumor overgrowth/regrowth, reintervention rates, and dysphagia-progression-free and overall survival rates were compared in the two groups. RESULTS Stent placement or removal was technically successful and well tolerated in all patients. The dysphagia score was significantly improved in both groups after stent placement (P < .01). Each of the stent-related complications was less in group A than in group B but there was no significant difference. However, the total number of patients with one or more than one complications and who needed related reinterventions was significantly less in group A than in group B (P = .042 and .030, respectively). Tumor overgrowth/regrowth and the total number of patients who required related reinterventions was not significantly different (P = 1.00 and .517, respectively). Dysphagia-progression-free and overall survival rates were significantly longer in group A than in group B (P = .005 and .001, respectively). CONCLUSION Temporary placement of a covered retrievable expandable metallic stent with concurrent radiation therapy for patients with esophageal carcinoma is beneficial for reducing complications and related reinterventions and for increasing resultant survival rates compared with permanent esophageal stent placement.

[1]  E. Stange,et al.  Treatment of unresectable carcinoma of the esophagus or the gastroesophageal junction by mesh stents with or without radiochemotherapy. , 1998, International journal of oncology.

[2]  D. Cooper,et al.  The surgical management of malignant tumours of the oesophagus and cardia: A review of the results in 292 patients treated over a 15‐year period (1961–75) , 1979, The British journal of surgery.

[3]  Seong Ho Park,et al.  Benign and malignant esophageal strictures: treatment with a polyurethane-covered retrievable expandable metallic stent. , 1997, Radiology.

[4]  D. Sze,et al.  Delayed complications after esophageal stent placement for treatment of malignant esophageal obstructions and esophagorespiratory fistulas. , 2001, Journal of vascular and interventional radiology : JVIR.

[5]  R. Verkes,et al.  The effect of radiotherapy on dysphagia and survival in patients with esophageal cancer. , 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  H Y Song,et al.  Esophagogastric neoplasms: palliation with a modified gianturco stent. , 1991, Radiology.

[7]  M. Sivak,et al.  Endoscopic Nd:YAG laser therapy as palliation for esophagogastric cancer. Parameters affecting initial outcome. , 1985, Gastroenterology.

[8]  G. Falkson,et al.  Severe complications of 5-fluorouracil and cisplatin with concomitant radiotherapy in inoperable non-metastatic squamous cell oesophageal cancer after intubation--early termination of a prospective randomised trial. , 1992, European journal of cancer.

[9]  F. Keller,et al.  Malignant esophageal obstruction and esophagorespiratory fistula: palliation with a polyethylene-covered Z-stent. , 1997, Radiology.

[10]  F. Keller,et al.  Prior radiation and chemotherapy increase the risk of life-threatening complications after insertion of metallic stents for esophagogastric malignancy. , 1995, Gastrointestinal endoscopy.

[11]  S. Kim,et al.  Covered retrievable expandable nitinol stents in patients with benign esophageal strictures: initial experience. , 2000, Radiology.

[12]  W. Hop,et al.  A new design metal stent (Flamingo stent) for palliation of malignant dysphagia: a prospective study. The Rotterdam Esophageal Tumor Study Group. , 2000, Gastrointestinal endoscopy.

[13]  W. Hop,et al.  Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: a controlled, prospective study. , 1998, Gastrointestinal endoscopy.

[14]  I. Raijman.  ENDOSCOPIC MANAGEMENT OF ESOPHAGORESPIRATORY FISTULAS: EXPANDING OUR OPTIONS WITH EXPANDABLE STENTS , 1998, American Journal of Gastroenterology.

[15]  Ho-Young Song,et al.  Retrievable covered nitinol stents: experiences in 108 patients with malignant esophageal strictures. , 2002, Journal of vascular and interventional radiology : JVIR.

[16]  M. Frenken.  Best palliation in esophageal cancer: surgery, stenting, radiation, or what? , 2001, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[17]  K. Sung,et al.  Covered, expandable esophageal metallic stent tubes: experiences in 119 patients. , 1994, Radiology.

[18]  N. Vakil,et al.  A prospective trial of self-expanding metal stents in the palliation of malignant esophageal obstruction after failure of primary curative therapy. , 1996, Gastrointestinal endoscopy.

[19]  A. Flores.  Cancer of the esophagus and cardia: overview of radiotherapy. , 1989, Canadian journal of surgery. Journal canadien de chirurgie.

[20]  Takayuki Suzuki,et al.  Curative radiotherapy with high-dose-rate brachytherapy boost for localized esophageal carcinoma: dose-effect relationship of brachytherapy with the balloon type applicator system. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  I. Siddique,et al.  Does chemoradiation therapy increase the incidence of complications with self-expanding coated stents in the management of malignant esophageal strictures? , 1997, The American journal of gastroenterology.

[22]  R. Earlam,et al.  Oesophageal squamous cell carcinoma: I. A critical review of surgery , 1980, The British journal of surgery.

[23]  Y. Youssef,et al.  A prospective trial of short-course radiotherapy plus chemotherapy for palliation of dysphagia from advanced esophageal cancer. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[24]  M. Atkinson,et al.  Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy. , 1982, Gut.